Poxel and Sumitomo Dainippon Pharma Announce the Approval of TWYMEEG® (Imeglimin hydrochloride) for the Treatment of Type 2 Diabetes in Japan
TWYMEEG® is a first-in-class drug with a unique dual mechanism of action for the treatment of Type 2 Diabetes across...






